| aa |
amino acid |
| AcP2−
|
acetyl phosphate (Figure 20) |
| AIDS |
acquired immune deficiency syndrome |
| AMP·NO2−
|
adenosine 5′-monophosphate N(1)-oxide (Figure 12) |
| AMP2−
|
adenosine 5′-monophosphate (Figure 3) |
| ε-AMP2−
|
1,N6-ethenoadenosine 5′-monophosphate (Figure 12) |
| AnP2−
|
acetonylphosphonate (Figure 20) |
| arm |
heteroaromatic nitrogen base, e.g., bpy or phen |
| ATP4−
|
adenosine 5′-triphosphate |
| bpy |
2,2-bipyridine |
| DHAP2−
|
dihydroxyacetone phosphate (Figure 20) |
| dien |
diethylenetriamine = 1,4,7-triazaheptane |
| DNA |
deoxyribonucleic acid |
| dPMEA2−
|
dianion of 9-(4-phosphonobutyl)adenine = 3′-deoxa-PMEA2−
|
| G1P2−
|
glycerol 1-phosphate (= α-glycerophosphate; in many biochemistry texts also designated as glycerol 3-phosphate) (Figure 20) |
| HIV |
human immunodeficiency virus |
| L2−
|
any phosph(on)ate ligand (R-) |
| M2+
|
any divalent metal ion (in a few instances also Cu(bpy)2+ and Cu(phen)2+ are represented by this abbreviation) |
| N |
nucleophile |
| NDP3−
|
nucleoside 5′-diphosphate |
| NMP2−
|
nucleoside 5′-monophosphate |
| NTP4−
|
nucleoside 5′-triphosphate |
| PEEA2−
|
dianion of 9-[2-(2-phosphonoethoxy)ethyl]adenine |
| phen |
1,10-phenanthroline |
| PME2−
|
dianion of (phosphonomethoxy)ethane (=ethoxymethanephosphonate) [Equation (5)] |
| PMEA2−
|
dianion of 9-[2-(phosphonomethoxy)ethyl]adenine (Figure 3) |
| RNA |
ribonucleic acid |
| TuMP2−
|
tubercidin 5′-monophosphate = 7-deaza-AMP2− (Figure 12) |